Hope for mRNA vaccine against Multiple Sclerosis (MS)
2Hope for mRNA vaccine against Multiple Sclerosis (MS)
Scientists have announced that they can finally develop a treatment for Multiple Sclerosis (MS), which is seen in approximately 3 million people worldwide. The disease, which is currently incurable, causes paralysis in humans and causes premature death. British scientists announced that they will try a vaccine that uses mRNA technology behind Covid-19 vaccines on MS patients to reverse the effects of the disease.
A groundbreaking study in Australia earlier this year found that the incurable neurological disease Multiple Sclerosis (MS), which affects nearly 3 million people worldwide and can cause poor mobility, lethargy, fatigue and paralysis, is the same infection that causes glandular fever. He found that it was triggered by the Epstein-Barr virus.
However, US Covid vaccine manufacturer Moderna is currently testing an Epstein-Barr vaccine designed to prevent people from contracting the virus.
mRNA VACCINE WILL BE GIVEN TO MS PATIENTS
Experts have now announced that they want to give this vaccine to MS patients to see if it can slow the progression of the disease and reduce the severity of symptoms.
Professor of virology at the University of Warwick in England, who will chair the new study. Dr. "The link between Epstein-Barr and MS is no longer questionable. We believe that if we can neutralize the virus levels in the blood with a vaccine, it will be possible to reverse some of the worst symptoms of this terrible disease," said Lawrence Young.
WHAT IS MS DISEASE?
Multiple Sclerosis (MS), on the other hand, occurs when the immune system gets out of control, attacking and damaging the myelin sheath, the protective covering on the brain and spinal nerves.
This leads to devastating symptoms such as poor mobility and numbness in the limbs, as well as mental health problems. Multiple sclerosis (MS) currently has no cure and often causes patients to die sooner.
On the other hand, in 2018, an Australian study developed an experimental drug therapy that trains the immune system to hunt Epstein-Barr in MS patients. 6 out of 10 patients who were given the drug saw significant improvements in their symptoms.
prof. Dr. “The results of this trial were remarkable. Even severe symptoms such as paralysis and vision loss were reversed. "However, producing this experimental drug developed in Australia proved to be expensive and very tedious."
Young said a similar, less expensive treatment could be created using the technology behind the Moderna and Pfizer/BioNTech Covid-19 vaccines, known as mRNA, designed to tailor vaccines to target specific cells in the body.
“We plan to collaborate with one of these MRNA companies in the near future and launch a trial to see if we can fight MS using a vaccine,” Young said. made the statement.